UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000019163
Receipt number R000022156
Scientific Title Phase II study evaluating safety of transoral surgery assisted by a flexible-tip rigid endoscope for T1/2 laryngopharyngeal cancer
Date of disclosure of the study information 2015/10/01
Last modified on 2023/04/06 12:47:50

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Phase II study evaluating safety of transoral surgery assisted by a flexible-tip rigid endoscope for T1/2 laryngopharyngeal cancer

Acronym

Phase II study evaluating safety of transoral surgery assisted by a flexible-tip rigid endoscope for T1/2 laryngopharyngeal cancer

Scientific Title

Phase II study evaluating safety of transoral surgery assisted by a flexible-tip rigid endoscope for T1/2 laryngopharyngeal cancer

Scientific Title:Acronym

Phase II study evaluating safety of transoral surgery assisted by a flexible-tip rigid endoscope for T1/2 laryngopharyngeal cancer

Region

Japan


Condition

Condition

T1/2 laryngopharyngeal squamous cell carcinoma

Classification by specialty

Oto-rhino-laryngology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To evaluate safety and efficacy of transoral surgery assisted with a flexible tip rigid endoscope for laryngopharyngeal cancer

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

postoperative complication rate
assessment day: postoperative day 30

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Device,equipment Maneuver

Interventions/Control_1

transoral surgery assisted by a flexible-tip rigid endoscope

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1. Squamous cell carcinoma is proven by histopathological examination.
2. Primary site is oropharynx, hypopharynx or larynx.
3. T stage is T1 or 2. It is determined by endoscope and image diagnosis(CT or MRI).
4. Tumor is lesser than a half-circle of pharynx.
5. Tumor does not invade nasopharynx, prevertebral fascia, mandible, prerigoid muscles, skull base or carotid artery.
6. Patients do not excluded by clinical N stage.
7. There is no distant metastasis.
8. Patients agree by signing on consent forms.

Key exclusion criteria

non

Target sample size

20


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Daisuke Nishikawa

Organization

Aichi Cancer Center Central Hospital

Division name

head and neck surgery

Zip code


Address

1-1 Kanokoden, Chikusa-ku Nagoya, Aichi Japan

TEL

052-761-6111

Email

dsknishi@aichi-cc.jp


Public contact

Name of contact person

1st name
Middle name
Last name Nishikawa Daisuke

Organization

Aichi Cancer Center Central Hospital

Division name

head and neck surgery

Zip code


Address

1-1 Kanokoden, Chikusa-ku Nagoya, Aichi Japan

TEL

052-761-6111

Homepage URL


Email

dsknishi@aichi-cc.jp


Sponsor or person

Institute

Aichi Cancer Center Central Hospital

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2015 Year 10 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2014 Year 12 Month 22 Day

Date of IRB

2014 Year 12 Month 22 Day

Anticipated trial start date

2014 Year 12 Month 22 Day

Last follow-up date

2016 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2015 Year 09 Month 30 Day

Last modified on

2023 Year 04 Month 06 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000022156


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name